Research
Night Sweats and Cancer: What the Evidence Says About Lymphoma
Night sweats are one of the classic "B symptoms" of lymphoma, alongside unexplained fever above 38°C and weight loss of more than 10% in six months. That association is real, but it is often misunderstood. In the largest recent UK primary-care cohort, only 1.7% of patients presenting with night sweats received a cancer diagnosis within 12 months, and the strongest specific link was with haematological cancers, not solid tumours. Among people who already have lymphoma, roughly 25 to 30% report B symptoms at Hodgkin lymphoma diagnosis, and roughly 24 to 31% of US diffuse large B-cell lymphoma patients in a SEER-based analysis. This page summarizes what the evidence actually shows. It is educational only, not diagnostic advice.
By the Sweat Explained Editorial Team · Published 2026-07-19 · Last reviewed 2026-07-19 · Educational information, not medical advice.
Key statistics at a glance
1.7%
of primary-care patients presenting with night sweats were diagnosed with cancer within 12 months (UK cohort of 7,857)
Watson et al., BMJ Oncology 2024
25-30%
of Hodgkin lymphoma patients present with B symptoms (fever, night sweats, weight loss)
NCI PDQ; StatPearls Hodgkin Lymphoma
24-31%
of diffuse large B-cell lymphoma patients in the US had B symptoms at diagnosis (by race, SEER 1992-2007)
Shenoy et al., Cancer 2011
>38°C, >10%, 6 mo
B-symptom definition: fever above 38°C, drenching night sweats, weight loss over 10% in 6 months
Ann Arbor / Lugano staging
up to 70%
of advanced-stage Hodgkin lymphoma patients report B symptoms at diagnosis, vs 10-25% in limited-stage disease
Balkan Med J 2013
What "B symptoms" actually are
In lymphoma staging (originally the Rye system, updated in the Ann Arbor and Lugano classifications), each stage is subclassified A or B. The B designation covers three specific constitutional symptoms: unexplained fever above 38°C, drenching night sweats, and unexplained weight loss of more than 10% of body weight in the six months before diagnosis. Pruritus and alcohol-induced lymph node pain are recognized additional symptoms but are not part of the formal B-symptom definition today.
The mechanism is thought to involve pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) released by tumour tissue. The presence of B symptoms upstages the disease and, in most subtypes, is associated with worse prognosis. In Hodgkin lymphoma, however, the US National Cancer Institute's PDQ summary specifically notes that night sweats alone (without fever or weight loss) do not confer an adverse prognosis.
The base rate: night sweats rarely mean cancer
The most important number for anyone worrying about cancer is the base rate. A UK electronic-health-records cohort of over 1.6 million adults, published in BMJ Oncology in 2024, followed patients from the first time they presented with each of 15 red-flag symptoms. Of 7,857 patients whose index symptom was night sweats, 137 (1.7%) were diagnosed with cancer within 12 months. Compared with a symptom-free reference group, night sweats were most strongly linked to haematological cancers, but the absolute risk was still well below the UK's 3% referral threshold for most groups.
Primary-care reviews reach a similar conclusion qualitatively: most persistent night sweats in general practice are not a sign of a serious underlying disorder, and follow-up studies find no significant mortality difference between people with and without night sweats. The classic association with lymphoma is important, but it does not invert the base rate.
B-symptom prevalence in lymphoma patients
Turned around, the numbers look different. Among people who already have lymphoma, B symptoms are common, though far from universal, and depend on stage and subtype.
| Group | Value |
|---|---|
| Hodgkin lymphoma, limited stage (I-II) | 20% (range 10-25%) |
| Hodgkin lymphoma, overall at diagnosis | 28% (range 25-30%) |
| Hodgkin lymphoma, advanced stage (III-IV) | 70% (up to 70%) |
| Diffuse large B-cell lymphoma, US (white patients) | 24% |
| Diffuse large B-cell lymphoma, US (black patients) | 31% |
Source: NCI PDQ; StatPearls; SEER-18 analysis; Balkan Med J. Chart is an original rendering of the cited data.
The three B symptoms, precisely defined
The formal definitions matter, because "night sweats" as a colloquial complaint is very common, whereas B-symptom night sweats are more narrowly defined.
| Symptom | Definition |
|---|---|
| Fever | Unexplained fever with temperature above 38°C |
| Night sweats | Drenching night sweats requiring change of bed clothes |
| Weight loss | Unexplained loss of more than 10% of body weight in the 6 months before diagnosis |
Source: NCI PDQ Adult Hodgkin Lymphoma Treatment summary; Ann Arbor and Lugano staging classifications.
What lymphoma-associated night sweats tend to look like
Descriptive literature on lymphoma consistently emphasizes that B-symptom night sweats are typically drenching (soaking bedclothes and often requiring changes), persistent rather than sporadic, and usually accompanied by other systemic features (unexplained fevers, weight loss, painless lymph node enlargement, sometimes pruritus). Isolated mild night sweats without any of these associated features are a much less specific finding.
This is not a diagnostic checklist. Menopause, thyroid overactivity, infections, medications, sleep apnea, and reflux can all produce night sweats that feel intense to the person experiencing them. The combination of new drenching night sweats plus an unexplained lump, persistent fever, or significant weight loss is what typically prompts further evaluation.
Other cancers linked to night sweats
Beyond lymphoma, night sweats are described in leukaemia, some solid tumours (renal cell carcinoma, hepatocellular carcinoma, ovarian carcinoma) and neuroendocrine tumours (carcinoid, pheochromocytoma). In the QCancer men's algorithm derived from UK primary-care records, night sweats were associated with roughly a 5-fold increased risk of haematological cancer, and smaller increases for lung and renal tract cancers, but the positive predictive value of night sweats alone was low.
In practice, cancer investigation is triggered by the combination of symptoms, examination findings (such as unexplained lymphadenopathy or an abdominal mass), and blood-test abnormalities, not by night sweats in isolation.
Features that make evaluation reasonable
Night sweats alone are rarely a sign of cancer, but certain combinations of features do warrant a discussion with a clinician. Reviews and referral guidelines highlight the following:
- Drenching night sweats that soak bed clothes or sheets, persisting for weeks rather than resolving.
- Unexplained weight loss of more than about 5-10% of body weight in 6 months.
- Persistent unexplained fevers, especially above 38°C.
- A new, painless lump, especially in the neck, armpit, or groin, or persistent swelling that does not resolve.
- New generalized itching without a rash, especially after a hot bath or alcohol.
- Any night sweats in the setting of known immune compromise, high TB-exposure risk, or ongoing infection.
- This is not a diagnostic checklist and this page is not medical advice; a clinician can put these features in context.
Methodology and limitations
This page uses the following primary sources: the NCI PDQ Adult Hodgkin Lymphoma Treatment summary (constitutional-symptom definitions and prognostic notes); the StatPearls Hodgkin Lymphoma chapter (~30% B-symptom prevalence at diagnosis); a single-centre Hodgkin lymphoma series in Balkan Medical Journal (Kilickap et al. 2013, cited 25-30% B-symptom prevalence as typical); a SEER-based analysis of 38,522 US diffuse large B-cell lymphoma cases (Shenoy et al., Cancer 2011, 24% of white and 31% of black patients presented with B symptoms); Barclay et al., BMJ Oncology 2024 (cancer incidence following 15 primary-care presenting symptoms, night sweats cohort n=7,857, 1.7% cancer at 12 months); the Hippisley-Cox QCancer algorithm derivation paper (Br J Gen Pract 2013); the Mold 2012 systematic review of night sweats in J Am Board Fam Med; and the AAFP 2020 review on persistent night sweats.
Limitations: B-symptom prevalence estimates in lymphoma vary by subtype, stage, geography, and study design. The 1.7% figure from the BMJ Oncology 2024 study applies to UK primary-care patients whose index recorded symptom was night sweats, not to every person who ever has a night sweat, and the paper's authors caution that some patients present with an unrecorded prior symptom. Nothing on this page constitutes a diagnostic threshold, referral advice, or medical advice. Symptoms that concern you are worth discussing with a qualified clinician, who can consider infection, medication effects, hormones, sleep disorders, and rare but treatable malignancies together.
Frequently asked questions
- Do night sweats mean I have cancer?
- Usually not. In a UK primary-care cohort of 7,857 patients whose index symptom was night sweats, only 1.7% were diagnosed with cancer within 12 months. Most persistent night sweats are explained by menopause, medications, sleep disorders, infections, thyroid issues, or benign causes.
- What are B symptoms in lymphoma?
- B symptoms are three constitutional features used in lymphoma staging: unexplained fever above 38°C, drenching night sweats, and unexplained weight loss of more than 10% of body weight in the 6 months before diagnosis. Their presence upstages the disease and, in most subtypes, is associated with worse prognosis.
- How common are B symptoms at Hodgkin lymphoma diagnosis?
- Approximately 25 to 30% overall, though this rises to as much as 70% in advanced-stage disease and is lower (roughly 10 to 25%) in limited-stage disease. Nodular sclerosis is often diagnosed at earlier stages and is less likely to present with B symptoms than mixed cellularity or lymphocyte-depleted subtypes.
- How common are B symptoms in non-Hodgkin lymphoma?
- In a SEER-based analysis of 38,522 US diffuse large B-cell lymphoma cases (1992-2007), 24% of white and 31% of black patients presented with B symptoms. Rates vary by subtype and stage; aggressive lymphomas such as DLBCL present with B symptoms more often than indolent subtypes.
- Do night sweats alone predict worse outcomes in lymphoma?
- In Hodgkin lymphoma, the US National Cancer Institute's PDQ summary specifically notes that fever and weight loss are the most prognostically important B symptoms, and that night sweats alone (without fever or weight loss) do not confer an adverse prognosis.
- What lymphoma-associated night sweats typically feel like
- They are usually described as drenching (soaking the bed clothes and often requiring changes), persistent rather than sporadic, and accompanied by other features such as unexplained fevers, weight loss, painless lymph-node enlargement, or itching. Isolated mild night sweats without other systemic features are a much less specific finding.
Sources
Primary peer-reviewed studies and official sources first, then reviews and institutional framing (secondary).
- National Cancer Institute. Adult Hodgkin Lymphoma Treatment (PDQ®) - Health Professional Version. US National Institutes of Health, current online summary. NCI
- Kaseb H, Babiker HM. Hodgkin Lymphoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 Jun 26. NCBI Bookshelf
- Barclay ME, Renzi C, Harrison H, Torralbo A, White B, Ip SHY, Usher-Smith J, Lange J, Pashayan N, Denaxas S, Wood AM, Antoniou A, Lyratzopoulos G. Cancer incidence and competing mortality risk following 15 presenting symptoms in primary care: a population-based cohort study using electronic healthcare records. BMJ Oncology. 2024;3(1):e000500. Full text
- Shenoy PJ, Malik N, Nooka A, Sinha R, Ward KC, Brawley OW, Lipscomb J, Flowers CR. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. 2011;117(11):2530-2540. DOI
- Kilickap S, Barista I, Ulger S, Celik I, Selek U, Yildiz F, Kars A, Ozisik Y, Tekuzman G. Clinical features and prognostic factors of Hodgkin's lymphoma: a single center experience. Balkan Med J. 2013;30(2):178-185. DOI
- Hippisley-Cox J, Coupland C. Symptoms and risk factors to identify men with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2013;63(606):e11-e21. (secondary) Full text
- Mold JW, Holtzclaw BJ, McCarthy L. Night sweats: a systematic review of the literature. J Am Board Fam Med. 2012;25(6):878-893. (secondary) Full text
How to cite this page
Sweat Explained. Night Sweats and Cancer: What the Evidence Says About Lymphoma. Published 2026-07-19; last reviewed 2026-07-19. Available at: https://sweatexplained.com/research/night-sweats-lymphoma-cancer
Please cite the original studies for the underlying figures. Journalists are welcome to link to this page; the charts are original renderings of the cited data.